Patent · US Active

Salt of 3-[(3-{[4-(4-morpholinylmethyl)-1H-pyrrol-2-yl]methylene}-2-oxo-2,3-dihydro-1H-indol-5-yl)methyl]-1,3-thiazolidine-2,4-dione, its preparation, and formulations containing it

US10245270B2 · kind B2 · utility

0Cited by

4References

8Claims

0Family size

Assignee

LES LABORATOIRES SERVIER · FR

Inventors

Alexandre Le Flohic · Bolbec, FR
Jérôme GUIDOTTI · Yvetot, FR
Philippe Letellier · Bellac, FR

Key dates

Filing date	Sep 4, 2018
Grant date	Apr 2, 2019
Priority date	—
Expiry date	Sep 4, 2038

Classification

Technology area (CPC C)Chemistry; Metallurgy
CPC primaryC07D417/14
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

3-[(3-{[4-(4-morpholinylmethyl)-1H-pyrrol-2-yl]methylene}-2-oxo-2,3-dihydro-1H-indol-5-yl)methyl]-1,3-thiazolidine-2,4-dione methanesulphonate of formula (II):Medicinal products containing the same which are useful in treating cancer.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.